Technology markets are changing fast. This brief is essential reading for you to identify the key forces shaping the prospects for your business. In this piece, Datamonitor's analyst specializing in pharmaceutical technology will outline the changes in your market, explain which trends will have the biggest impact and highlight who will benefit from the developments in pharmaceutical technology.

Report Highlights
To thrive and survive turbulent times, a top priority of pharmaceutical and biotechnology companies will be to continue to streamline operations, particularly back-end, non-research activities, to reduce costs and time-to-market.

Biotechnology methodologies will play a key role in the development of breakthrough drugs and shaping the future of the life science industry as the popularity of personalized medicine grows and drug development becomes increasingly focused on niche patient populations based on their biological makeup.

Pharma companies will need to leverage advanced IT tools as the global sales & marketing landscape dramatically changes to encompass a broader array of stakeholders and markets.
[Studien Infos ausblenden]

Figure 1: The pharmaceutical industry faces many challenges and has a long, difficult road ahead 2
Figure 2: The long and costly drug discovery and development process 4
Figure 3: Pharma companies continue to announce big layoffs, but now the mid-market enters the game 5
Figure 4: Adoption level of SCM solutions in China and India 9
Figure 5: IT budget allocation for R&D and non-R&D processes in China and India 13
[Tabellenverzeichnis ausblenden]